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Abstract 
A 2-month-old female infant was referred to DebRA Mexico from the Regional Children’s 
Hospital because of a generalized dermatosis from birth characterized by multiple blisters 
and erosions on the trunk, face and limbs, associated with minor trauma. A skin biopsy 
showing subepidermal blisters associated with a dermal infiltrate of Giemsa-positive cells and 
CD117-positive antibody was consistent with the diagnosis of bullous mastocytosis. 
Treatment with oral antihistamines, topical steroids, and antibiotics was initiated, leading to a 
remission of the lesions. © 2014 S. Karger AG, Basel 
Introduction 
Bullous mastocytosis (BM) is an unusual variant of the mast cell disease characterized 
by widespread bullae as its main cutaneous feature. These are caused by mast cell degranu-
lation, which releases proteases that lead to dermoepidermal separation. We present the 
case of a 2-month-old female patient who was referred to DebRA Mexico with a diagnosis of 
epidermolysis bullosa (EB). 
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A 2-month-old female infant was referred to DebRA Mexico from the Children’s Hospital 
because of generalized erosions, crusts, and blisters 1–5 cm in diameter on the trunk, face, 
and limbs (fig. 1). The blisters were associated with trauma, suggesting congenital EB 
simplex, the reason for referral to DebRA Mexico. The patient presented with a history of 
these clinical findings from the third week of birth. 
On physical examination, brown macules and nodules 1–2 cm in diameter were ob-
served around the blisters. Darier’s sign was observed when the macules and nodules were 
intentionally rubbed. The oral mucosa was not affected. A blood count, blood chemistry, and 
liver function tests were normal; a liver ultrasound and CT were also normal, while tryptase 
levels were elevated (47.4 ng/ml). A skin biopsy showed a subepidermal blister with an 
abundant mast cell infiltrate in the dermis with Giemsa stain and CD117-positive antibody, 
confirming the diagnosis of BM (fig. 2). 
Oral cetirizine 0.2 mg/kg/day, betamethasone valerate cream 0.1%, and topical fusidic 
acid 20 mg once a day were prescribed. The blisters and ulcers subsided 2 weeks after 
starting treatment. 
Discussion 
Mastocytosis is a group of diseases associated with elevated infiltration of mast cells in 
tissues [1]. Soter [2] described various forms of skin manifestations, including urticaria 
pigmentosa, solitary mastocytoma, telangiectasia macularis eruptiva perstans, and diffuse 
and erythrodermic forms, which also include BM, being the least frequent of these skin 
manifestations [1, 3]. 
BM is characterized by isolated or grouped blisters from birth that contain a se-
rous/hemorrhagic fluid, leaving hyperpigmented brown macules. Lesions can arise on the 
scalp, trunk, and the extremities [4], in a manner similar to our patient. 
Orkin et al. [5] described two forms of presentations: the neonatal form, with a greater 
risk of severe complications and extracutaneous involvement, and late onset, which shows 
minimal extracutaneous involvement but with a better prognosis. The latter was the 
presentation in our patient. 
Mutations in the c-Kit (CD117) gene that encodes KIT, a transmembrane receptor that 
causes the differentiation, maturation, and proliferation of mast cells, have been detected. A 
deficiency of the KIT receptor or increased activity of the C-kit gene would cause abnormal 
proliferation of mast cells [6]. Systemic affection such as hepatomegaly, splenomegaly, 
lymphadenopathy, and long bone osteolysis may be present [1, 3, 4]. If skin lesions are 
rubbed, mast cell degranulation is triggered that forms a wheal, a change known as Darier’s 
sign that is pathognomonic of the disease. Blister formation is due to the accumulation of 
tryptase, a protease that accumulates between the dermis and the epidermis [6]. Diagnosis is 
clinical and is confirmed by the presence of mast cells in a skin biopsy stained with HE, 
Giemsa, and CD117 [7]. 
The differential diagnosis includes EB, IgA bullous disease, bullous pemphigoid, staphy-
lococcal scalded skin syndrome, and incontinentia pigmenti [8]. 
Kleewein et al. [9] reported a case similar to ours in which a 10-month-old patient was 
referred to EB-Haus Austria showing widespread blisters, hence the errors of diagnosis that 
occur in the medical community. 
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Treatment for BM consists of reducing the factors that trigger mast cell degranulation. 
The use of antihistamines and sodium cromoglycate are beneficial in most patients [10]. 
Topical steroid use can improve the evolution of the lesions. It is important to prevent 
infections in skin blisters by using topical antibiotics. 
Due to the similarity between EB and BM, the latter must be considered in the differen-
tial diagnoses of congenital EB, especially in a newborn with scattered blisters and erosions 
related to trauma or spontaneous appearance. 
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Fig. 1. a Erosions on the chest and left arm. b Hemorrhagic blisters with crusts suggestive of EB. Note the 
presence of erythema around the maculas after the friction characteristic of Darier’s sign. c Ulcer of the left 
leg, 127 × 101 mm (300 × 300 DPI). 
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Fig. 2. a Monocellular infiltrates are observed in the papillary and reticular dermis, associated with 
subepidermal multicenter blisters. HE. ×10. b Subepidermal blister without inflammatory infiltrate. HE. 
×40. c CD117-positive infiltrate, dermis cells (×20). d Subepidermal blister associated with CD117-positive 
mast cells (×40). 106 × 127 mm (300 × 300 DPI). 
 
